Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma
Tan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park, Thangaraj Jaya Lakshmi, Sung‐Hoon Jung, Hyeoung‐Joon Kim, Je‐Jung Lee
Topics & Concepts
PomalidomideCancer researchImmunotherapyImmune checkpointImmune systemCytotoxic T cellBlockadeTumor microenvironmentMultiple myelomaMedicineT cellPharmacologyImmunologyBiologyReceptorBortezomibInternal medicineBiochemistryIn vitroImmunotherapy and Immune ResponsesMultiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers